- These are not official programs of the American College of Rheumatology.
- All industry sessions will be available on-demand on the virtual meeting platform until March 10, 2022.
Dual Perspectives in Psoriatic Disease Management: Zero Disease Activity in One or More Domains
Exhibit Hall Theater A and UCB Booth #1101, McCormick Place Convention Center
Developed and offered by UCB, Inc.
Dual Perspectives in Psoriatic Disease Management: Zero Disease Activity in One or More Domains
Innovation Theater A
Developed and offered by UCB, Inc.
Mystery Diagnosis: Recognizing X-linked Hypophosphatemia (XLH)
Developed and offered by Kyowa Kirin.
An Expert Review of the Evolving Clinical Profile of SAPHNELO® (anifrolumab-fnia) and Emerging Evidence
Innovation Theater B
Developed and offered by AstraZeneca.
Mystery Diagnosis (Continued)
Developed and offered by Kyowa Kirin.
Neuroimmune Modulation for Rheumatoid Arthritis
Developed and offered by SetPoint Medical.
From Camelids to the Clinic: The Potential of Nanobodies® in Rheumatology
Developed and offered by MoonLake Immunotherapeutics.
From Camelids to the Clinic (Continued)
Developed and offered by MoonLake Immunotherapeutics.
Language Matters: Sjögren’s Disease, Not Syndrome
Developed and offered by Sjögren’s Foundation.
A Clinical Approach to Hypophosphatasia
Developed and offered by Alexion.
There’s a Ton to be Excited About Because Tonmya is Now Approved
Developed and offered by Tonix.
Autoimmune-Associated Interstitial Lung Disease: The Patient Journey and Physician Perspective
Innovation Theater A
Developed and offered by Boehringer Ingelheim Pharmaceuticals, Inc.
Addressing the Heterogeneity of Sjögren’s Disease
Developed and offered by Amgen.
The Clock Is Ticking: A Rheumatologist-Dermatologist Chat on Slowing Structural Damage Progression in Adult Patients With Active PsA
Developed and offered by Johnson & Johnson.
IgG4-RD in Focus: Clinical Presentation, Diagnosis, and Management
Innovation Theater B
Developed and offered by Amgen.
The Next Chapter in CAR T-Cell Therapy: Rapcabtagene Autoleucel Clinical Trials in Autoimmune Diseases
Developed and offered by Novartis.
Descartes-08 Clinical Updates: Expanding BCMA CAR-T Into Rheumatology
Developed and offered by Cartesian.
Clinical Trials Series: Avalyn Pharma
Developed and offered by Avalyn Pharma.
The JAK-STAT Odyssey: Past Discoveries, Present Understanding, and Future Horizons
Innovation Theater A
Developed and offered by Pfizer, Inc.
The RESOLUTION Trial: Advancing Autoimmune Treatment with ALLO-329, a Dual-Targeted Allogeneic CAR T Therapy
Developed and offered by Allogene Therapeutics.
A Product Theater for Zepbound® (tirzepatide) Injection Including an Affordability Solution for Taltz® (ixekizumab) Patients
Innovation Theater B
Developed and offered by Eli Lilly and Company.
Shifting the Trajectory: Early Intervention Strategies in SLE
Grand Horizon Ballroom C, Marriott Marquis Chicago
Developed and offered by GSK
Unspoken, Unmeasured: The Burden of Obesity in PsA
Grant Park Room, Hyatt Regency McCormick Place
Developed and offered by Eli Lilly & Company
The SpA Puzzle: Unraveling Inflammation Piece by Piece
Grand Horizon Ballroom AB, Marriott Marquis Chicago
Developed and offered by UCB, Inc.
Taking a New Look at Psoriatic Arthritis and Its Comorbidities Through the Lens of TYK2 Inhibition
Hyatt Regency McCormick Place, Regency Ballroom CDE
Developed and offered by Peerview Institute for Medical Education. Supported by Bristol Myers Squibb.
Advancing Care in Autoimmune Diseases: Addressing Unmet Needs and Future Directions in B-cell Depetion Strategies
Marriott Marquis Chicago, Grand Horizon Ballroom EF
Developed and offered by Novartis Pharmaceuticals Corporation.
Advances in SLE Management: Expert Perspectives on Targeting DORIS Remission and Emerging Clinical Data for a Novel Treatment
Hyatt Regency McCormick Place, Regency Ballroom AB
Developed and offered by AstraZeneca.
Reaching Further: Exploring Long-term Data on a Treatment with a Well Documented Safety Profile for Adults with Active PsA
Innovation Theater A
Developed and offered by AbbVie, Inc.
From Conception to Delivery: Managing Lupus in Pregnancy
Developed and offered by GSK.
Triple Therapy in Lupus Nephritis: Navigating the Guidelines
Developed and offered by GSK.
FSR’s Initiative to Ensure FMLA Benefits for Clinical Trial Participants
Developed and offered by Foundation for Sarcoidosis Research.
Who We Are: Arcare/ Infinity National Specialty Pharmacy
Developed and offered by Arcare.
Importance of PROs in Real World Evidence-Based Research
Developed and offered by National Databank for Rheumatic Diseases.
Addressing Rheumatology Disparities: Small Volunteer Asks = Big Wins
Developed and offered by ACR Collaborative Initiatives Committee.
Update on Autoimmune Biomarkers
Developed and offered by Labcorp.
There’s a Ton to be Excited About Because Tonmya is Now Approved
Developed and offered by Tonix.
Early Initiation of Treatment: Evolving Management of Lupus and LN
Innovation Theater A
Developed and offered by GSK.
Bridging Evidence and Experience: SAPHNELO® (anifrolumab-fnia) Real-World Patient Case Discussion
Developed and offered by AstraZeneca.
YOUR ROLE IN THE CAR T RESEARCH ERA: The Rheumatologist’s Guide to Who, When, and How
Innovation Theater B
Developed and offered by Bristol Myers Squibb
AVISE CTD: A Decade of Validation Driving Lupus Diagnostic Accuracy, Seronegative RA Biomarker Innovation, and Novel T-Cell Biomarkers for Lupus
Innovation Theater A
Developed and offered by Exagen.
Discover a Treatment Option for Macrophage Activation Syndrome (MAS)
Innovation Theater B
Developed and offered by Sobi.
Incorporating New Data Into Patient Care for Lupus Nephritis
Regency Ballroom CDE, Hyatt Regency McCormick Place
Developed and offered by Paradigm Medical Communications, LLC. Supported by Genentech.
Fatigue, Flares, and Function: Bridging the Gap from Clinical Trials to Patient Care in SLE
Marriott Marquis Chicago, Grand Horizon Ballroom AB
Developed and offered by UCB Biopharma SRL.
Sjöcasing Sjögren’s: An Exhibit of Heterogeneous Disease, Unpredictable Progression, and Evolving Manifestations
Marriott Marquis Chicago, Grand Horizon Ballroom EF
Developed and offered by Novartis Pharmaceuticals Corporation.
Targeting IL-23: From Immunopathogenesis to Joint Preservation, Skin Clearance, and Intestinal Symptom Improvement
Hyatt Regency McCormick Place, Regency Ballroom AB
Developed and offered by Johnson & Johnson.
Therapeutic Frontiers in Rheumatology: Investigating the Effects of FcRn Blockade on Autoimmunity
Marriott Marquis Chicago, Grand Horizon Ballroom C
Developed and offered by argenx.
Dermatomyositis in Focus: What Do We Know about Immunoglobulin Therapy?
Innovation Theater A
Developed and offered by Octapharma
Advancing Care in Lupus Nephritis: Exploring the Evolving Landscape
Innovation Theater B
Developed and offered by Genentech
A Targeted Treatment Approach for Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Innovation Theater A
Developed and offered by AstraZeneca.
The Intersection Where Rheumatology Meets Dermatology
Innovation Theater B
Developed and offered by Biogen.
Understanding Collaborative Care in Autoimmune-Associated Interstitial Lung Disease (ILD)
Grand Horizon E/F Ballroom, Marriott Marquis Chicago
Developed and offered by Boehringer Ingelheim Pharmaceuticals, Inc.
CAR T Cell Therapy in Autoimmune Disease: A Potential Emerging Treatment Option
Hyatt Regency McCormick Place, Regency Ballroom AB
Developed and offered by Cabaletta Bio.
The Evolving Understanding of Sjögren’s Disease: Patient Experiences, Pathophysiological Insights, and Novel Treatments on the Horizon
Marriott Marquis Chicago, Grand Horizon Ballroom AB
Developed and offered by PRIME Education, LLC. Supported by Novartis Pharmaceuticals Company.
A Day in the Life of Patients with PsA: Understanding the Implications of Disease Domains and Clinical Care Considerations
Grand Horizon Ballroom C, Marriott Marquis Chicago
Developed and offered by Med Learning Group. Supported by AbbVie, Inc.
The Rheumatologist’s Guide to Diagnosing and Managing IgG4-Related Disease
Hyatt Regency McCormick Place, Jackson Park
Developed and offered by Med Learning Group. Supported by Amgen.
Aiming for Remission: Expert Perspectives on a Shared Outcome Target Across Rheumatic Diseases
Hyatt Regency McCormick Place, Grant Park
Developed and offered by Bristol Myers Squibb.
From Delay to Damage: Changing the EGPA Trajectory with Early Diagnosis and Biologic Therapy
Hyatt Regency McCormick Place, Regency Ballroom CDE
Developed and offered by Integritas Communications. Supported by AstraZeneca
Clinical Pearls for Rheumatologists: Diagnosing and Managing Fibrosing Interstitial Lung Diseases
Marriott Marquis Chicago, Great Lakes Ballroom AB
Developed and offered by IMed Learning Group. Supported by Boehringer Ingelheim Pharmaceuticals, Inc.
SPARTAN GRAPPA ASAS Educational Symposium on Axial Spondyloarthritis and Psoriatic Arthritis
Marriott Marquis Chicago, Great Lakes Ballroom EF
Developed and offered by SPARTAN.